BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
ICICI Direct Report
Hester Biosciences Ltd.’s Q2 FY21 revenues grew 20.8% to Rs 53.4 crore mainly due to 27.8% growth in poultry segment to Rs 34.3 crore as feed price stabilised and demand for milk and eggs improved.
Animal healthcare segment grew 16% YoY to Rs 13.8 crore. Ebitda margins improved 458 basis points YoY to 29.6% mainly due to lower staff and other expenses, partly offset by lower gross margins.
Ebitda grew 43% YoY to Rs 15.8 crore. Profit after tax grew 2.4% to Rs 6.7 crore in line with operational performance and a higher tax rate.
Click on the attachment to read the full report:
DISCLAIMER
This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the brokerage and do not represent the views of BloombergQuint.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.
As a Subscriber you get
Stories
RECOMMENDED FOR YOU
POPULAR